241 related articles for article (PubMed ID: 21167421)
1. A case of pemphigoid vegetans with autoantibodies against both BP180 and BP230 antigens.
Suda-Takayanagi T; Hara H; Ohyama B; Hashimoto T; Terui T
J Am Acad Dermatol; 2011 Jan; 64(1):206-8. PubMed ID: 21167421
[No Abstract] [Full Text] [Related]
2. A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180.
Osawa M; Ueda-Hayakawa I; Isei T; Yoshimura K; Fukuda S; Hashimoto T; Okamoto H
J Am Acad Dermatol; 2014 Jun; 70(6):e129-31. PubMed ID: 24831331
[No Abstract] [Full Text] [Related]
3. Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting.
Desai N; Allen J; Ali I; Venning V; Wojnarowska F
Australas J Dermatol; 2008 Aug; 49(3):137-41. PubMed ID: 18638220
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid.
Yang B; Wang C; Chen S; Chen X; Lu X; Tian H; Yu M; Zhang D; Shi Z; Zhou G; Zhang F
Indian J Dermatol Venereol Leprol; 2012; 78(6):722-7. PubMed ID: 23075641
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.
Feng S; Wu Q; Jin P; Lin L; Zhou W; Sang H; Shao C
Int J Dermatol; 2008 Mar; 47(3):225-8. PubMed ID: 18289320
[TBL] [Abstract][Full Text] [Related]
6. [Anti-desmoglein 1 and 3 antibody, anti-BP180(NC16a) antibody, anti-BP230 antibody].
Amagai M
Nihon Rinsho; 2010 Jun; 68 Suppl 6():614-7. PubMed ID: 20942145
[No Abstract] [Full Text] [Related]
7. Two cases of childhood bullous pemphigoid.
Toyama T; Nakamura K; Kuramochi A; Ohyama B; Hashimoto T; Tsuchida T
Eur J Dermatol; 2009; 19(4):368-71. PubMed ID: 19451055
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.
Sitaru C; Dähnrich C; Probst C; Komorowski L; Blöcker I; Schmidt E; Schlumberger W; Rose C; Stöcker W; Zillikens D
Exp Dermatol; 2007 Sep; 16(9):770-7. PubMed ID: 17697150
[TBL] [Abstract][Full Text] [Related]
9. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.
Iwata Y; Komura K; Kodera M; Usuda T; Yokoyama Y; Hara T; Muroi E; Ogawa F; Takenaka M; Sato S
Arch Dermatol; 2008 Jan; 144(1):41-8. PubMed ID: 18209167
[TBL] [Abstract][Full Text] [Related]
10. Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects.
Wieland CN; Comfere NI; Gibson LE; Weaver AL; Krause PK; Murray JA
Arch Dermatol; 2010 Jan; 146(1):21-5. PubMed ID: 20083688
[TBL] [Abstract][Full Text] [Related]
11. Type XVII collagen ELISA indices significantly decreased after bullous pemphigoid remission.
Kusajima E; Akiyama M; Sato M; Natsuga K; Shimizu H
Int J Dermatol; 2011 Feb; 50(2):238-40. PubMed ID: 21244398
[No Abstract] [Full Text] [Related]
12. Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid.
Kamiya K; Aoyama Y; Noda K; Miyake T; Yamaguchi M; Hamada T; Tokura Y; Iwatsuki K
J Dermatol Sci; 2015 Apr; 78(1):77-9. PubMed ID: 25771164
[No Abstract] [Full Text] [Related]
13. Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid.
Schneiderbauer R; Martinache S; Engstner M; Enk AH; Hadaschik EN
Dermatol Ther; 2016 Nov; 29(6):419-423. PubMed ID: 27550573
[TBL] [Abstract][Full Text] [Related]
14. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.
Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E
Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345
[TBL] [Abstract][Full Text] [Related]
15. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
[TBL] [Abstract][Full Text] [Related]
16. Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China.
Feng S; Lin L; Jin P; Wu Q; Zhou W; Sang H; Shao C
Int J Dermatol; 2008 Jan; 47(1):24-8. PubMed ID: 18173596
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients.
Charneux J; Lorin J; Vitry F; Antonicelli F; Reguiai Z; Barbe C; Tabary T; Grange F; Bernard P
Arch Dermatol; 2011 Mar; 147(3):286-91. PubMed ID: 21422334
[TBL] [Abstract][Full Text] [Related]
18. A case of bullous pemphigoid with IgG antibodies against LAD-1, but not BP180 NC16a domain or BP230.
Miyashita K; Iioka H; Miyagawa F; Ishii N; Hashimoto T; Asada H
Eur J Dermatol; 2018 Apr; 28(2):248-250. PubMed ID: 29378676
[No Abstract] [Full Text] [Related]
19. Case of pemphigoid vegetans positive with both BP180 and BP230 in enzyme-linked immunosorbent assays.
Nagamoto E; Fujisawa A; Jinnin M; Koga H; Ishii N; Hashimoto T; Yoshino Y
J Dermatol; 2014 Jul; 41(7):667-8. PubMed ID: 24985550
[No Abstract] [Full Text] [Related]
20. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
Bernard P; Reguiai Z; Tancrède-Bohin E; Cordel N; Plantin P; Pauwels C; Vaillant L; Grange F; Richard-Lallemand MA; Sassolas B; Roujeau JC; Lok C; Picard-Dahan C; Chosidow O; Vitry F; Joly P
Arch Dermatol; 2009 May; 145(5):537-42. PubMed ID: 19451497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]